NUDCD1 antibody (Middle Region)
Quick Overview for NUDCD1 antibody (Middle Region) (ABIN953777)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 193-223, Middle Region
-
Specificity
- This antibody recognizes Human NUDCD1 / CML66 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 193-223 amino acids from the Central region of Human NUDCD1
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NUDCD1 (NudC Domain Containing 1 (NUDCD1))
-
Alternative Name
- NUDCD1 / CML66
-
Background
- NUDCD1 (CML66) contains 1 CS domain. It may play an oncogenic role in ways of favoring tumor cells proliferation, invasion and metastasis-associated with multiple pathways. NUDCD1 is expressed in leukemias and a variety of solid tumor cell lines. Northern blot analysis showed expression in normal tissues restricted to testis and heart, and no expression was found in hematopoietic tissues.Synonyms: Chronic myelogenous leukemia tumor antigen 66, NudC domain-containing protein 1, Tumor antigen CML66
-
Molecular Weight
- 66756 Da
-
Gene ID
- 84955
-
NCBI Accession
- NP_001121683
Target
-